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ABSTRACT

Previous research has proposed that the somatosensory feedback generated
during exercise is a key component in regards to the mechanism underlying the
therapeutic effects of exercise on the motor symptoms of Parkinson’s disease (PD).
This thesis aimed to further examine the contributions of different forms of
somatosensory feedback during exercise in PD in order to understand the mechanism
for symptom improvements that certain exercise studies report.
This randomized, controlled exercise study consisted of three treadmill
groups, with the RATE and MAGNITUDE groups serving as the experimental
conditions, while the CONTROL condition was an active comparator treadmill
walking group. The RATE group attempted to elicit a rapid sampling rate from
somatosensory afferents by having participants walk at a high cadence. The
MAGNITUDE group attempted to generate a signal from somatosensory receptors
that was larger or richer in magnitude by having participants wear ankle weights with
the premise that the additional weight would cause tension sensitive golgi tendon
organs to increase signaling. The CONTROL treadmill group served as an active
comparator control group where participants walked regularly. Each condition
finished with 13 participants with idiopathic PD.
All treadmill groups trained at the same aerobic intensity, duration, and
frequency. however, only the RATE group improved in the primary outcome
measure (motor section of the Unified Parkinson’s Disease Rating Scale (UPDRSIII)) after exercise. Furthermore, this same condition improved on the upper limb
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score of the UPDRS-III, possibly indicative of an overall improvement in basal
ganglia (BG) functioning. Main effects of time were reported for step length in
velocity across all treadmill training groups during both self-paced and maximal
walking speeds. No changes in any measures of postural control were detected.
This study demonstrates that exercise that generates a high rate of
somatosensory feedback from appears to be the most capable of improving motor
symptoms of PD. Furthermore, gait improvements from treadmill training were
independent of improvements in UPDRS-III, and are likely an effect of motor
learning.
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PROBLEM STATEMENT
Studies examining exercise interventions for the treatment of the motor
symptoms in PD have been popular in the last decade, as the need for complementary
strategies to pharmaceutical treatment has become more apparent. However, despite
the body of research that has been conducted on exercise and PD, the actual
mechanism(s) responsible for the therapeutic effect of that remain largely unknown.
Furthermore, due to the lack of randomized, controlled exercise studies, current
evidence of exercise as a reliable rehabilitation method remains limited.
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Chapter 1: Prologue
AN OVERVIEW OF PARKINSON’S DISEASE
Parkinson’s disease (PD) is a progressive neurological disorder that manifests
when a substantial amount of dopaminergic neurons in the basal ganglia (BG) have
died. Prevalence over the age of 70 is approximately 1 in 100, making PD the second
most common neurodegenerative disease second only to Alzheimer’s (Pringsheim,
Jette, Frolkis & Steeves, 2014). Symptoms of PD are widespread, and are classified
into motor and non-motor categories. Motor symptoms include tremor, bradykinesia,
rigidity, postural instability, impaired gait, and poor proprioception (Guttman, Kish,
& Furukawa, 2003; Rocchi, Chiari, & Horak, 2012; Schaafsma et al., 2003). Nonmotor symptoms include, but are not limited to; mood disturbances, digestive
complications, and autonomic system dysfunction (Park & Stacy, 2009). Symptoms
worsen in severity as the disease progresses, eventually leading to loss of
independence and a reduced quality of life.
Although there is not yet a cure for PD, treatment options do exist. Dopamine
replacement therapy (DRT) consisting of the synthetic dopamine precursor Levodopa
(L-DOPA) is the most common and accessible method for managing the motor
symptoms of the disease (Sprenger & Poewe, 2013). Although the drugs ameliorate
the symptoms, their use is associated with several unpleasant side effects such as
dyskinesias, orthostatic hypotension, hallucinations, and on/off fluctuation (Fahn,
1996). Also of importance is the diminished therapeutic effect after prolonged usage
as well as its possibility to be toxic to remaining dopaminergic neurons (Fahn, 1996;
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Fahn et al. 2004). Furthermore, postural instability and gait dysfunction do not
respond well to dopaminergic medication, leaving the two symptoms that are
associated with the highest morbidity in PD mainly untreated (Sethi, 2008; Hely,
Morris, Reid, & Trafficante, 2005). Thus, the value of determining if alternative
treatment methods such as exercise are capable of improving these symptoms is
important for the development of an ideal motor symptom improvement strategy.
The gold standard for assessing motor symptom severity is the motor section
of the Unified Parkinson’s Disease Rating Scale (UPDRS-III), which is a battery of
14 tests performed by a trained assessor (Movement Disorder Society Task Force on
Rating Scales for Parkinson’s Disease, 2003). Each test is scored on a scale from 0-4,
with 0 representing normal or no impairment, and 4 representing extreme
impairment/inability to perform the task. Although the test is subjective, the UPDRS
III demonstrates high reliability and validity across all severities and is a universally
accepted rating scale for patients with PD (Movement Disorder Society Task Force
on Rating Scales for Parkinson’s Disease, 2003). The UPDRS-III is designed to
assess the cardinal symptoms of PD: bradykinesia (slowness), postural instability and
gait dysfunction, tremor, and akinesia (difficulty initiating movement). New
pharmaceutical treatments are also assessed with the UPDRS-III (Jones & Murray
2014). If exercise should be considered worthy of prescription by medical
practitioners as a complementary or alternative therapy, the efficacy of exercise to
improve motor symptoms should be measured on the same scale to allow for a direct
comparison.
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EXERCISE AS THERAPY FOR THOSE WITH PD
Exercise has been shown to improve the condition of several chronic diseases
and promote good health in general (Mattson, 2000; Haskell et al., 2007). Naturally,
the efficacy of exercise and physical activity to improve the motor symptoms of PD
has been a popular area of research in recent years. However, despite the amount of
research that has been conducted, fundamental questions about what specific forms of
exercise are therapeutic for PD, and more importantly the mechanisms behind the
therapeutic benefits remain largely unanswered. A more thorough understanding of
which specific types of exercise are most efficacious will allow health practitioners to
prescribe more successful exercise therapy for those with PD. Specifically,
understanding the actual traits (frequency, intensity, type and time) of exercise that
provide motor symptom relief allows for more knowledge based exercise
prescription.
EXERCISE AND ANIMAL MODELS OF PD
Initial studies involving exercise and Parkinson’s disease have utilized rodent
models which use either 6-hydroxydopamine (6-OHDA) or 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) as toxic agents. These agents act selectively on
DA producing neurons, providing a reliable model to examine how exercise affects
the dopaminergic system. Lau et al. (2011) examined the effects of a continuous
treadmill based aerobic program in an MPTP rat model with aims to shed light on the
exact mechanisms responsible for exercise-induced neuroprotection. Rats that
exercised improved the function of nigrostriatal neurons, determined by synaptic
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dopamine (DA) levels and dopamine active transporter (DAT) activity. An
upregulation of neurotrophic factors such as brain-derived neurotrophic factor
(BDNF) and Glial-derived neurotrophic factor (GDNF) were also noted, and has been
reported in other works involving rat models (Tillerson, Caudle, Reveron & Miller,
2003).
Results from exercise in animal models of PD shed light upon the neural
changes that may be responsible for motor symptom relief. It remains unclear if
benefits from exercise and physical activity experienced in humans with PD can be
attributed to these same factors, however, human studies examining acute bouts of
aerobic exercise have shown an increase in synaptic DA concentration immediately
after exercise (Wang et al., 2000). Although examining DA function is outside the
scope of this thesis, animal models provide insight to the exercise derived neural
changes responsible for symptom improvement.
EXERCISE IN HUMAN POPULATIONS WITH PD
Several modalities of exercise have been tested in human models of PD with
mixed results. It appears that only certain forms of exercise are capable of providing
post treatment reductions in UPDRS-III scores. Interventions that lead to reductions
in overall UPDRS-III scores should be considered more successful than those that
lead to improvements in an outcome measure that is similar to the training protocol.
This is because improvements in UPDRS-III scores may be more indicative of
improvements in the BG network (, rather than an improvement that can be explained
by practice or motor control theories.
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i. Treadmill based exercise
A variety of treadmill training (TT) interventions have been studied within the
PD population comprising of varying intensities, speeds, and the use of body weight
supported treadmill training (BWSTT). Benefits are dependent upon the actual type
of TT intervention, but overall have shown to be a promising rehabilitative strategy
for those with PD.
Fisher examined varying intensities of BWSTT with patients in early stages of
PD. Patients in the high intensity group were trained at 75% of their age adjusted
maximum heart rate (AAMHR), determined by the Karvonen formula (220-age).
The low intensity group was trained at no greater than 50% of their AAMHR, and the
zero intensity group attended educational sessions. The exercise based groups trained
for 24 sessions over 8 weeks, while the zero intensity education group attended 4
separate information sessions. Outcome measures included the UPDRS III, selfselected and fast paced gait analysis, and a cortical excitability measure derived from
transcranial magnetic stimulation (TMS). A slight, but non-significant improvement
was reported in the UPDRS III. Significant improvements in spatiotemporal measures
of gait including step length (1.48m to 1.56m, p<.05) and in both self-selected
(1.46m/s to 1.52m/s, p<.05) and fast paced (1.91m/s to 2.00m/s, p<.05) walking
velocities. Cortical excitability, determined by a TMS based cortical silent period
(CSP) improved to levels that were closer to age-matched control participants,
however, only in the high intensity training group. The authors attributed the
improvements in cortical excitability to a possible upregulation of neurotrophic
factors as a result of high intensity exercise. This study did not report average
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walking speed or cadence of the actual training sessions, since maintaining a
percentage of AAMHR was the main objective during training sessions.
Miyai et al. examined the effects of BWSTT in comparison to a traditional,
gait based physiotherapy (PT) intervention not involving treadmill use. This study
sampled moderately severe PD participants, and it was proposed that the body weight
support (BWS) would allow them to train with a more proper gait pattern. The
authors proposed that the proper gait pattern leads to a higher quality of afferent
somatosensory feedback being sent to the CNS. The study was a crossover with the
sample (n=10) being equally split into 4 weeks of each condition with 5 participants
receiving BWSTT first, and 5 receiving traditional PT first. The BWSTT condition
consisted of 12 sessions each lasting 45 minutes including 9 minutes of rest time.
Body weight support was adjusted throughout each session starting with 20% for 12
minutes, 10% for 12 minutes, and finally 0% for the last 12 minutes. Speed was
started at 0.5 km/hr and adjusted until 3.0km/hr as tolerated. The BWSTT
intervention improved UPDRS III by 18% (18.2 to 15.0, p<.001), gait speed became
quicker (10.0sec/10m to 8.3sec/10m, p<.05), and less steps were needed over a 10
metre walk (22.3 to 19.6, p<.01). Variability of gait was unable to be measured due
to gait characteristics being obtained by stopwatch and counting. Although this study
highlights the benefits of BWSTT, no comparison group of regular treadmill training
was available.
To further examine the efficacy of BWSTT within PD, Toole [19] had three
separate conditions consisting of a group that was not under any BWS, a group with
25% of their bodyweight unloaded, and lastly a group that trained with an additional
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5% of their body weight. This study was conducted to determine if BWS has an
influence on therapeutic effect of TT within PD. Participants trained 3 times a week
for 6 weeks, with each session lasting 20 minutes. Intensity was relatively low, with
patients in all groups training at 60% of their AAMHR. Despite what condition
patients were in, improvements were observed in gait, UPDRS III, and balance
measures. Reductions in UPDRS III scores were minimal (as only a 9%
improvement was noted). This study concluded that the amount of body weight
support during treadmill training does not affect symptom improvement.
To determine the effect of high velocity treadmill walking, Herman employed
a progressive and speed dependent TT program under the premise that bradykinesia
and hypokinetic gait can be remedied by practicing to walk at a fast velocity. The
program was 6 weeks long, and sessions ran four times a week. Patients were
harnessed in order to prevent falling, but bodyweight was not unloaded. Treadmill
speed was dependent on comfortable overground walking speed, which was assessed
at the start of every week. During the first 2 weeks, patients trained at speeds at or
below overground walking speed. By week 3, PD participants walked at speeds
ranging from 5-10% greater than their overground walking speed. A large reduction
in UPDRS III was noted (scores improved by 25% (29 to 22, p<.05)). Measures of
gait also improved, as self-paced gait became faster (1.11m/s to 1.26m/s, p<.05) after
TT, most likely due to greater stride length (1.17m to 1.25m, p<.05). This study was
based upon progressively increasing walking speed and provided the actual gait
velocity in which participants were trained at. However, it is important to consider
that the study lacked a control group, and was an open label design.
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The immediate (Pohl et al., 2003) and long-term (Cakit, Saracoglu, Hakan &
Erdem, 2007) effects of fast paced treadmill programs have also been studied in the
PD population. Although the previously mentioned Herman study was also based
upon progressive speed dependent training, percentages relative to comfortable pace
were used. The following studies differ because the speed was based upon
percentages of maximal overground walking speed, rather than comfortable walking
speed. After one bout of maximal speed dependent treadmill training, increases were
reported in self-paced gait velocity, alongside a reduction in percentage of gait spent
in double support. To investigate the long term effects of maximal speed training, an
8 week, 16 session intense speed dependent treadmill training demonstrated an
increase in maximal tolerated walking speed from 1.9km/h (+/-0.75km/h) to 2.6km/h
(+/-0.77km/h) p<.001 (Cakit et al., 2007). Unfortunately, UPDRS III was only
measured at baseline, so the effect of maximal speed training on motor symptom
severity remains unknown.
Despite there being several previous TT interventions published for PD,
several fundamental questions remain. It appears that nearly every sort of treadmill
training despite speed, intensity or use of BWSTT has the ability to improve gait.
However, only UPDRS III improvements and changes in cortical excitability were
reported in high intensity protocols (Herman, 2007; Fisher, 2008).

TT interventions

that alter cadence but match intensity (% of MHR) between training groups are
needed to determine if the rate of exercise has an interaction with the intensity in
regards to providing therapeutic benefit for motor symptoms of the PD.
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ii. Forced Exercise
Ridgel, Vitek & Alberts define forced exercise (FE) as exercise that is
augmented mechanically to assist the participant in achieving and maintaining an
exercise rate greater than their preferred rate of exercise. The group utilized a
stationary tandem bicycle setup where a trainer would pedal at the front of the cycle,
effectively controlling the cadence of the rear cranks. By forcing the participant on
the back of the cycle to maintain the cadence set by the trainer, the participant would
be able to achieve and maintain a rate of exercise (in regards to cadence) greater than
they could on their own while providing the same amount of effort. This group was
the first to adapt an FE paradigm that originally showed promise in rodent and animal
models of PD (Lau, 2011; Tillerson, 2003). Their FE intervention resulted in a within
group 35% decrease in total UPDRS-III score, in contrast to a control cycling group
which saw no change, despite exercising at a matched duration, frequency and
intensity (% of MHR). The only identified difference between the successful FE
group and the control condition was a difference in pedaling cadence. Improvements
in the FE group were also seen in upper limb outcome measures unrelated to the
training protocol, leading researchers to conclude that the exercise may have caused
global improvements in BG functioning. A separate study by the same group
showed that even a single bout of FE was capable of reducing bradykinesia and
tremor (Ridgel, Peacock, Fickes & Kim, 2012). These results demonstrated that not
all exercise that is matched by aerobic intensity is equal in its therapeutic effect.
Since pedaling cadence was the only reported difference between groups, the authors
proposed that faster sampling rates of afferent somatosensory information
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experienced by FE group could be responsible for the improvement in BG
functioning.
iii. Body awareness/other - Is somatosensory training the missing link?
The contributions of somatosensory feedback during exercise are highlighted
in the next few exercise programs, which are neither aerobic, intense, or speed based.
Improvements in UPDRS-III scores have been reported in interventions such as Tai
Chi (Yang, Li, Gong & Zhu, 2014), PD SAFEx (Sage & Almeida, 2009, Sage &
Almeida, 2010), and Qi Gong (Schmitz-Hubsch, Pyfer, Kielwen, Fimmers, &
Klockgether, 2006). These interventions focus on body awareness, and force
Parkinson’s patients to rely heavily on somatosensory information to maintain
balance and stability. The mechanisms responsible for the improvement of symptoms
are still unknown for body awareness based exercises, however, an improvement in
the processing of somatosensory information may in part be responsible for the
improvements in motor symptoms (Sage, 2008; Sage, 2009). Work that has
examined sensory feedback during movement in PD have supported that the
processing of somatosensory information is disrupted in Parkinson’s disease
(Abbruzzese & Berardelli, 2003; Zia et al. 2000; Konczak et al., 2007). Additionally,
other research has proposed that the deficits in sensory processing may actually
contribute to the motor symptoms of PD (Jacobs & Horak, 2006; Abbruzzese, 2004).
Due to the possibility that poor processing of somatosensory information within the
BG contributes to the motor symptoms of the disease, an improvement in integration
of somatosensory information could be a causal factor in regards to improvements in
motor symptoms.
10

MUSCLE SPINDLE AND GOLGI TENDON ORGAN FUNCTION/PHYSIOLOGY
The term somatosensory feedback refers to the afferent sensory message
provided by proprioceptors in the body that allow for the detection of movement,
muscle tension and physical location in space. The two primary proprioceptors
discussed in this thesis are muscle spindles and Golgi tendon organs (GTO). Muscle
spindles are stretch-sensitive mechanoreceptors that are found in virtually all
mammalian skeletal muscle. Their function is to provide the central nervous system
with information about length and changes in length of a muscle (Proske, 1997). In
regards to the afferent signal that is created sent to the CNS, as the muscle is
lengthened, the spindle increases its frequency of discharge in proportion to the
length of the sarcomere (Burke, Hagbarth & Löfstedt, 1978).
The other proprioceptor discussed in this thesis is the GTO, which provides
the CNS with information regarding the tension that a muscle fiber is subject to.
GTO’s are very sensitive to changes in tension, as the activation threshold for this
particular proprioceptor is very low (Jami, 1992). As the GTO is put under more
strain, the output of action potentials becomes more frequent, providing the CNS
information that the muscle is under greater load. Furthermore, as more motor units
are recruited to perform a task that requires more tension, a greater quantity of GTOs
will begin to discharge (Horcholle-Bossavit, Jami, Petit, Vejsada & Zytnicki, 1988).
In the middle section of this thesis, the terms RATE and MAGNITUDE are
used as descriptors for somatosensory feedback that the exercise programs are
intended to generate. During regular walking, the CNS is receiving information from
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both the GTO’s and muscle spindles as muscles extend and contract while being
subjected to varying tension. The RATE group, which consists of walking at a fast
cadence causes length sensitive muscle spindles to discharge more frequently, as a
greater amount of gait cycles are occurring in a given period of time. This more
frequent discharge from length sensitive muscle spindles is the basis for the RATE
title, as the CNS receives this stretch/shortening message more frequently. The
treadmill program that was deemed “MAGNITUDE” was intended to generate a
greater discharge from tension sensitive GTO’s. This was accomplished by having
participants wear ankle weights during walking in an effort to elicit greater tension at
the flexors of the hip and extensors of the knee during walking. Assuming that the
ankle weights lead to greater muscle tension during gait, the greater amount of
discharge from GTO’s particularly during toe off and swing would provide a signal to
the CNS that is greater in magnitude. Thus, compared to regular treadmill walking
the feedback from GTO’s would be of greater magnitude due to the use of the ankle
weights.
THERAPEUTIC CONTRIBUTIONS OF SOMATOSENSORY FEEDBACK
Recently, the contributions of afferent, somatosensory feedback from muscle
spindles, golgi tendon organs and joint receptors has been proposed to be a
mechanism responsible for the therapeutic effects of exercise for those with PD
(Alberts et al., 2011; Ridgel et al., 2012). This hypothesis is supported by research
that shows that afferent feedback has the ability to alter corticomotor excitability
(Coxon, Stinear & Byblow, 2005; Cheng J, Brooke JD, Misiaszek JE, Staines WR,
1995). Furthermore, work reporting therapeutic effects from whole body vibration
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therapy in PD has also proposed somatosensory feedback as the mechanism
responsible for motor symptom improvement (King, Almeida & Ahonen, 2009; Haas
CT, Turbanski K, Kessler K & Schmidtbleicher, 2006). The incoming somatosensory
feedback may reset or perturb the abnormally slow neural rhythms that occur in the
Parkinsonian brain (King, Almeida & Ahonen, 2009). Exercise based evidence for
this hypothesis stems from forced exercise studies where training variables such as
heart rate and output (watts) are matched between groups, while cadence differs
(Alberts et al., 2011). Only groups that trained at fast cadences received therapeutic
benefits, leading the authors to conclude that a higher rate of sampling from
somatosensory afferents was the only difference between groups.
Although the argument that high rates of sampling of somatosensory
information is what leads to therapeutic benefits of high cadence exercise, it is
important to consider that the previously mentioned body awareness and resistance
based exercises that have also been shown to be capable of improving the motor
symptoms rely on somatosensory information, but in a different manner. Body
awareness based exercises are not quick or high rate in nature, but rather are slow and
generate high magnitudes of somatosensory feedback. Therefore, it is possible that
exercise interventions that generate greater magnitudes of somatosensory feedback by
increasing the discharge frequency from GTO’s may be just as effective as those that
are based upon generating high rates of somatosensory feedback in regards to their
therapeutic qualities.
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THESIS OBJECTIVES
The objective of this thesis is to explore the therapeutic capability of three
different treadmill exercise programs. The first treadmill condition is deemed the
RATE group, and will have participants walk while maintaining a fast cadence. The
next treadmill condition is the MAGNITUDE group, where participants will walk
with ankle weights. Lastly, a CONTROL treadmill exercise program consisting of
participants walking at their voluntary speed will serve as an active comparator. The
variations in types of treadmill training programs were carefully manipulated with
the intention to vary the type of somatosensory feedback they generate. This work
will hopefully provide insight to the therapeutic contributions of somatosensory
feedback during exercise, and allow for a further understanding of which specific
traits of exercise for those with PD are beneficial.
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Chapter 2
The therapeutic contributions of somatosensory feedback during exercise in
Parkinsons disease; a randomized, controlled trial.
ABSTRACT
Background: Somatosensory feedback generated from exercise has been
hypothesized to be in part responsible for the therapeutic effects of forced-exercise in
Parkinson’s disease (PD). Objective: To explore the influence of different forms of
somatosensory feedback and their contribution to motor symptom improvement from
exercise in PD. Methods: 48 patients with idiopathic PD were randomized into 3
different treadmill exercise programs (RATE, MAGNITUDE, CONTROL).
Participants were evaluated before and after the program using the motor section of
the Unified Parkinson’s Disease Rating Scale (UPDRS-III) and objective measures of
both gait and postural control. All programs lasted 6 weeks with sessions occurring 3
times a week. Results: Baseline measurements revealed no statistical differences
between groups. 9 participants withdrew. Despite all groups exercising at a matched
intensity, frequency and duration, only the RATE group significantly reduced their
UPDRS-III (23.35  8.13 to 18.85  7.17, P<.01). Furthermore, this group improved
on an upper limb subsection of the UPDRS-III (12.00  5.39 to 9.15  4.14, P<.01).
Conclusion: A high sampling rate of somatosensory feedback appears to be a trait of
exercise that contributes to its therapeutic effect in PD. Those exercising for
therapeutic benefit with PD should consider including activity that is rapid and
repetitive in nature.
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INTRODUCTION

Parkinson’s Disease (PD) is a progressive movement disorder with motor
symptoms such as tremor, bradykinesia, rigidity, postural instability, and gait
impairment (Guttman, Kish & Furukawa, 2003; Rocchi, Chiari & Horak, 2002).
Dopamine replacement therapy (DRT) is the most common and accessible treatment
for motor symptom management (Rascol, Payoux, Ory, Ferreira, Brefel-Courbon &
Monastruc, 2003; Parkinson Study Group, 2000). Although DRT ameliorates cardinal
motor symptoms, its use is commonly accompanied by bothersome physical and
mental side effects (Fahn, 1996; Fahn et al., 2004). Furthermore, postural instability
and gait dysfunction respond minimally to DRT, leaving two symptoms associated
with the high morbidity in PD minimally treated (Sethi, 2008; Hely, Morris, Reid &
Trafficante, 2005). The compromising and incomprehensive aspects of DRT stress
the importance of developing alternative and complimentary methods of motor
symptom management in PD.
Exploring the efficacy of exercise and physical activity to improve the motor
symptoms of PD has been a popular area of research in recent years. (Ridgel,
Peacock, Fickes & Kim, 2012; Herman, Giladi, Gruendlinger & Hausdorff, 2008;
Alberts, Linder, Penko, Lowe & Phillips, 2011; Sage & Almeida, 2009; Sage &
Almeida, 2010; Yang et al., 2014; Li, Harmer & Fitzgerald, 2012; Corcos et al., 2013,
Miyai et al., 2000). Aerobic exercise on treadmill, bicycle, resistance training, and
body awareness exercises such as Tai Chi, and Sensory Attention Focused Exercise
(PD SAFEx) have been shown to be successful in providing motor symptom relief,

19

measured by the motor subscale of the Unified Parkinson’s Disease Rating Scale
(UPDRS-III). However, despite the amount of research that has been conducted on
exercise and PD, which specific qualities and traits of exercise responsible for
evoking a therapeutic response remain largely unknown.
Recently, somatosensory feedback generated during exercise from muscle
spindles, golgi tendon organs and joint receptors has been proposed to contribute to
the therapeutic of exercise on the motor symptoms of PD (Ridgel et al., 2012; Alberts
et al., 2011) This is concurrent with research demonstrating that varying
somatosensory afferent feedback alters corticomotor excitability (Coxon, Stinear &
Byblow, 2005; Cheng, Brooke, Misiaszek & Staines, 1995). Furthermore, work
reporting therapeutic effects from whole body vibration therapy in PD has also
proposed somatosensory feedback as the mechanism responsible for motor symptom
improvement (King, Almeida & Ahonen, 2009; Turbanski, Haas, Schmidtbleicher,
Friedrich & Duisberg, 2005). The incoming somatosensory message relays through
the thalamus, and may reset or perturb abnormally slow and asynchronous neural
rhythms that occur in the Parkinsonian brain (Levy, Ashby, Hutchison, Lang, Lozano
& Dostrovsky, 2002; Brown, Olivviero, Mazzone, Insola, Tonali & Di Lazzaro, 2002;
Marsden, Limousin-Dowsey, Ashby, Pollak). Applied exercise based evidence for
this hypothesis stems from forced exercise (FE) studies where participants are
assisted to achieve an exercise intensity that they would not be capable of maintaining
on their own. In FE, variables such as heart rate and output (watts) are matched
between groups, while only cadence differs. Only the rapid cadence FE group
received therapeutic benefits leading to the possibility that a high rate of
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somatosensory sampling generated from FE was partly responsible for motor
symptom improvement reported (Alberts et al., 2011).
Although it is possible that a high rate of afferent sampling is a contributing
factor towards the therapeutic benefits of exercise, it is important to consider that
rapid, high cadence exercise is not the only type of exercise that has reported
UPDRS-III improvements. Previously mentioned body awareness and strength
training exercises are not quick or high rate in nature, but rather are slow and
methodical. In regards to afferent feedback, these types of exercise would generate
high magnitudes rather than high rates of somatosensory feedback. Therefore, if
somatosensory feedback generated from exercise is a contributing factor for
therapeutic benefit, it is possible that generating a high magnitude of feedback may
also be beneficial. This raises the need for a randomized, controlled study which
matches intensity, type, and duration of exercise while manipulating the
characteristics of somatosensory feedback that the participant receives. One way of
manipulating somatosensory feedback while keeping other training variables constant
is by using body weight supported treadmill training (BWSTT), as more body weight
can be removed to facilitate high rate exercise that would otherwise be difficult or
impossible for a Parkinson’s patient to maintain.
The aim of the current study was to explore the therapeutic contribution of
various forms of somatosensory feedback generated during exercise. It is
hypothesized that exercise that generates a high RATE of somatosensory feedback
will improve motor symptoms of the disease. Furthermore, the therapeutic effect of
somatosensory feedback that is greater in MAGNITUDE during exercise was
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explored. The objective is to provide those responsible for exercise prescription in PD
an indication of how somatosensory feedback may contribute to the therapeutic
improvements reported from certain forms of exercise in PD.

METHOD
Participants
Participants were recruited from the Sun Life Financial Movement Disorders
Research and Rehabilitation Centre (MDRC) at Wilfrid Laurier University in rolling
fashion from October 2013 to June 2014. Inclusion criterion included a diagnosis of
idiopathic PD, the ability to walk without the aid of an assistive device for 10 metres,
no history of cerebral or myocardial infarction, and no musculoskeletal issues in the
lower limbs or back that would affect ability to walk for sustained periods of time.
All participants provided PARmed-X forms that were signed by a physician to ensure
that they were fit for exercise. Participants were removed from the analysis if they
missed more than 2 sessions or changed medication at any time during the
intervention. Informed written consent was provided prior to any participation or
assessment. The study was approved by the Wilfrid Laurier University ethics board
and was registered with clinicaltrials.gov ID #NCT01987557.
Sample Size Calculation
A sample size of 13 was required to detect a 3.5 point change in the UPDRSIII with an assumption of 80% power. This chosen value was conservative estimate
based off of a minimally clinical important change (MCIC) which has been reported
to be between 2.4 and 2.7 points (Shulman et al., 2010)
Randomization
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Participants were randomized into 1 of 3 training groups by a random number
generator after initial assessments were completed to ensure that groups would be
comparable by UPDRS-III (Figure 1). Randomization was done by a researcher who
was not responsible for any assessments that were subjective in nature.
Outcome Measures
All tests were conducted within one week of the start of the intervention (Pre),
and again during the week following the cessation of the intervention (Post). All
assessments were done in the “On” state of Parkinsonian medication.
i. Unified Parkinson’s Disease Rating Scale (motor section)
The primary outcome measure was the motor section of the Unified
Parkinson’s Disease Rating Scale (UPDRS-III). An upper limb subscore (UPDRS-III
UL) was generated using items 20-25 of the UPDRS-III. A posture and gait subscore
(UPDRS-III PG) was generated with items 27-31. The UPDRS-III was conducted by
a certified clinical assessor who was blinded to group assignment.
ii. Spatiotemporal Aspects of Gait
Spatiotemporal aspects of gait were generated from a 7.9m GaitRITE
walkway (CIR Systems Inc, Havertown, PA) during self-selected, then maximal
overground walking speeds. The mean from 5 trials for each walking speed were
used for analysis.
iii. Postural Control
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Postural control was assessed on a Balance SD system (Biodex, Shirley, NY)
using the Postural Stability Test (PST) and modified Clinical Test of Sensory
Integration on Balance (m-CTSIB) modes. The postural stability mode assessed how
well a participant could maintain their centre of balance during quiet stance. This test
was repeated 3 times for 20 seconds each on platform stability level 8, which has
been validated in previous research (Arnold & Schmitz, 1998). The m-CTSIB
assessed the ability to integrate various forms of sensory feedback which has been
shown to be deficient in PD (Rinalduzzi et al., 2015). The m-CTSIB included 4
conditions that were each tested once for 30 seconds. Baseline (eyes open, firm
surface), vestibular/somatosensory interaction (eyes closed, firm surface),
somatosensory/visual interaction (eyes open, dynamic surface), and
somatosensory/vestibular interaction (eyes closed, dynamic surface). All values for
postural control measures represent deviations from the centre of the platform.
Training Statistics
In addition to outcome measures, training data provided by the BIODEX Gait
trainer 3.0 were recorded after each training session. Training metrics consisted of
heart rate, treadmill speed, stride length, and cadence. Cadence was measured in gait
cycles per minute and was derived from the total amount of steps taken during the 25
minute training session. Cadence (gait cycles per minute)=[(total steps/2)/25]. Heart
rate readings from the handles of the Biodex gait trainer 3.0 treadmills were recorded
every five minutes then averaged over the training session then converted to a
percentage using the standard Karvonen formula (220-age)
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Intervention
The study consisted of 3 separate treadmill based exercise interventions that
were deemed RATE, MAGNITUDE, and CONTROL. All interventions trained 3
times a week for 6 weeks for a total of 18 sessions. All participants trained on the
Biodex gait trainer 3.0 and wore the Biodex overhead harness to allow for the
manipulations bodyweight and for safety to be ensured.
Each session consisted of a 5 minute warm up where participants would walk
at a self-selected speed, followed by a 25 minute session that varied depending on
their group assignment, then an optional 2 minute cool down. Participants were
allowed to take breaks at anytime, however, break time was not included in the 25
minute session. If participants reached a heart rate that was above 75% of their
Karvonen age related maximum heart rate (AAMHR), they were given a rest, which
involved either walking slowly or sitting down until their heart rate dropped to below
70% of their Karvonen AAMHR.
i. “RATE”
Participants in this group were instructed to walk with as fast of a cadence
(gait cycles per minute) as possible during their training sessions. Body weight was
removed via the Biodex harness to facilitate high cadence walking. The amount of
bodyweight removed was determined by the participants’ preference. The protocol
was based off of a forced exercise (FE) regime that reported improvements in motor
function in those that bicycled at a cadence of 85.8(sd=0.8) revolutions per minute
(RPM) (Alberts et al, 2011). In an effort to replicate the high cadence, participants
were verbally reminded to keep the cadence of their gait as close to the mark of
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approximately 85 gait cycles per minute. To facilitate this, most participants in this
group used a greater amount of body weight support.
ii. “MAGNITUDE”
Participants wore ankle weights to increase the response from tension
sensitive golgi tendon organs (GTO’s) during gait that was larger in magnitude.
Participants were given the instruction to walk at their preferred pace. Men wore 3lb
weights on each ankle and women wore 2 lb weights on each ankle. For the first 3
sessions, the amount on each ankle was one pound less to allow for participants to
safely adjust to the ankle weights.
iii. “CONTROL”
In the control condition, participants were still harnessed and the amount of
bodyweight removed was determined by the participants’ preference. Participants
were told to train at their preferred walking pace. Gait cues were given occasionally
to promote proper gait.
Statistical Analysis
The data were analyzed with Statistica version 7 (Statsoft). For participant
characteristics at pre and training variables, one way ANOVAs were used to examine
group differences. Main and secondary outcome measure differences from pre to
post were analyzed with a repeated measures 3x2 (group by time) ANOVA. Post hoc
analyses were conducted using Fishers LSD. The significance level was set at .05.
For certain outcome measures, a post hoc analysis was run despite the absence of a
significant interaction between group and time. The use of more liberal statistics in
these scenarios is justified by these comparisons being planned and stated in the

26

hypothesis. Furthermore, the UPDRS-III changes reported were considered to be
moderately clinically meaningful differences (Shulman, 2010).
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Table 1: Protocol Summary
Condition
“Rate”

“Magnitude”

“Control”

Description

 Treadmill walking
 Treadmill walking
 Regular treadmill
with the goal of
with ankle weights
walking
maintaining as fast
of a cadence as
possible.

All participants trained at their preferred amount of body weight
Body Weight
support.
Support (BWS)
 Due to participants
 A varying amount of BWS was used for
training at a high
training sessions to adapt the exercise to
cadence, most
the capabilities of the participant.
participants
trained with a
considerable
amount of BWS.

All
participants  No cues for cadence were given to
Cadence
were instructed to
participants during training sessions.
walk with a step
rate that was fast as
possible and were
given verbal cues if
cadence
became
too slow.
 Intensity was based on participants’ % of age adjusted maximum
Intensity
heart rate using the *Karvonen formula (AAMHR).
 When AAMHR reached became greater than 75% participants were
given a rest until heart rate dropped to <70% AAMHR.
*Karvonen formula for AAMHR=(220-age)
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Figure 1: Randomization flow chart
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RESULTS

Participants
No significant differences in age, disease severity (UPDRS-III), or walking
velocity between groups at PRE were identified (Table 2).
Training Characteristics
Training intensity, which was based on a percentage of the Karvonen age
adjusted maximum heart rate (AAMHR) did not significantly differ between groups
(p=0.18) for total training sessions. Participants in the RATE condition trained at a
both faster velocity (p<.01), higher cadence (p<.001), and walked further compared to
those in other conditions (p=0.39). Stride length was similar between conditions
during training (Table 3).
Adverse Events
No major adverse events occurred during the study. 1 participant withdrew
due to hamstring pain, and another withdrew as a result of minor back pain (Figure
1).
Primary Outcome Measure
UPDRS-III
A main effect of time for all groups showed improvement on UPDRS-III
scores (F(1,36)=9.93, p<.01), however, only participants in the RATE condition
improved significantly (P<.01). A significant main effect of time was reported across
groups in an upper limb subscale (UPDRS-III UL) (F(1,36)=9.45, p<.01), again, only
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the RATE condition improved significantly in the UPDRS-III UL (p<.01). No
significant differences were detected in the posture and gait subscale (p>.05) (Table
4). An interaction between group and time was not statistically significant for total
UPDRS III F(2, 36)=1.0466, p=0.36, UPDRS III UL F(2,36)=2.39, p=0.11, and
UPDRS-III PG F(2,36)=1.26, p=0.30. A post hoc was completed on the UPDRS-III
and its subscales because a 4.5 point change in the RATE group is considered to be a
moderately clinically meaningful change (Shulman, 2010). Although statistical
significance was not reached in the interaction, the clinical importance of this change
merited the use of a post hoc test to examine this planned comparison.
Secondary Outcome Measures
Spatiotemporal Aspects of Gait
Self-paced gait
i. Velocity
A main effect of time was found for velocity (F(1,36)=9.75, p<.01). Fisher’s
LSD at post-hoc revealed that only the RATE (P<.01) and CONTROL (P<.05)
conditions improved significantly in self paced walking velocity (Table 5). A group
by time interaction was not significant F(2,36)=2.38, p 0.11.
ii. Stride Length
A main effect of time was reported for stride length (F(1,36)=11.83, p<.01).
Fisher’s LSD post-hoc showed that the RATE and CONTROL conditions improved
significantly (P<.05) (Table 5). A group by time interaction was not significant
F(2,36)=0.53, p=0.59.
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iii. Cadence
A main effect of group was detected for cadence (F(2,36)=3.65, P<.05). The
MAGNITUDE group walked with a significantly lower cadence compared to the
RATE and CONTROL groups (Table 5). A group by time interaction was not
significant F(2,36)=3.066, p=0.06.
Fast-paced gait
i. Velocity
A main effect of time on velocity was detected (F(1,36)=22.56, p<.001). Posthoc showed that the RATE (P<.01), MAGNITUDE (P<.05) and CONTROL (P<.01)
groups increased fast paced walking velocity (Table 6). A group by time interaction
was not significant F(2,36)=0.43, p=0.66
ii. Stride Length
A main effect of time was reported for stride length (F(1,36)=16.21, p<.001).
Fisher’s LSD post-hoc showed that the RATE and MAGNITUDE groups increased
their stride length during fast paced walking (P<.05) (Table 6). A group by time
interaction was not significant F(2,36)=0.41, p=0.67
iii. Cadence
No significant differences were detected for cadence during fast paced
walking.
Balance and Postural Control
Modified Clinical test of Sensory Integration on Balance (m-CTSIB)
No significant differences were observed in the m-CTSIB (Table 7).
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Postural Stability Testing (PST)
No significant differences reported in total, anteroposterior, or mediolateral PST
scores (Table 7).
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Table 2: Participant characteristics at baseline
Rate

Magnitude

Control

P value

N

13

13

13

n/a

Age

63.77 (7.01)

70.46 (9.52)

66.31
(9.07)

p=.16

UPDRS III "PRE"

23.00 (8.51)

22.96 (6.93)

22.46
(8.64)

p=.98

Gender

m=10, f=3

m=12, f=1

m=12, f=1

n/a

Self paced walking
velocity (cm/s)

116.19 (24.09)

122.54
(8.58)

116.21
(30.24)

p=.71

UPDRS-III, Unified Parkinson’s Disease Rating Scale (motor subsection). One way
ANOVA used to determine differences between groups at PRE. Disease severity
(UPDRS-III) and age were comparable at PRE. Bracketed numbers represent
standard deviations.
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Table 3: Training Statistics
Rate

Magnitude

Control

Sig

Intensity (% of AAMHR)

67% (3.83%)

68% (3.79%)

64% (5.60%)

p=.18

Velocity (km/h)

**5.63 (0.60)

4.60 (0.97)

4.63 (1.24)

p=.01

**80.21 (1.85)

59.68 (4.12)

59.85 (3.41)

p<.001

Total distance (m)

*2773.31 (310.22)

2318.62
(451.22)

2329.31
(661.29)

p=.039

Stride Length (cm)

151.69 (17.07)

160.00 (21.88)

148.15 (29.21)

p=0.42

Cadence (gait cycles per minute)

AAMHR, Karvonen based age adjusted maximum heart rate (220-age)
*P<.05 difference one way ANOVA between groups
**P<.01 difference one way ANOVA between groups

Table 4: UPDRS-III
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Rate

Magnitude

Control

Pre

23.35 (8.13)

22.96 (6.93)

22.46 (8.64)

Post

**18.81 (7.17)

20.69 (8.39)

20.92 (6.14)

Pre

2.92 (2.23)

2.88 (1.40)

4.04 (3.48)

Post

2.42 (1.89)

3.03 (1.81)

3.24 (3.04)

Pre

12.00 (5.39)

11.15 (4.14)

10.8 (5.02)

Post

**9.15 (4.14)

10.15 (5.90)

10.27 (4.62)

UPDRS-III

UPDRS-III PG

UPDRS-III UL

UPDRS=Unified Parkinson’s disease rating scale, PG=Posture and gait subscore
(items 27-31 of UPDRS), UL=Upper limb subscore (items 20-25 of UPDRS).
Bracketed numbers represent standard deviations.
**P<.01 using Fisher’s LSD post hoc within groups
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Table 5: Spatiotemporal aspects of self-paced gait
Rate

Magnitude

Control

Pre

117.07 (24.09)

122.64 (8.58)

116.2 (30.24)

Post

**129.38 (21.30)

125.56 (20.51)

*124.5 (32.33)

Pre

125.46 (26.29)

136.6 (11.87)

122.48 (28.52)

Post

*133.62 (27.04)

140.32 (17.48)

*128.77 (29.53)

Pre

111.59 (7.36)

107.85 (7.50)

112.97 (9.86)

Post

116.82 (8.88)

105.28 (10.45)

115.44 (10.90)

Velocity (cm/s)

Stride Length
(cm)

Cadence (steps
per minute)

Bracketed numbers represent standard deviations.
*P<.05 using Fisher’s LSD post hoc within groups
**P<.01 using Fisher’s LSD post hoc within groups

Table 6: Spatiotemporal aspects of fast paced gait
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Outcome Measure

Rate

Magnitude

Control

Pre

156.54 (37.33)

164.83 (22.32)

155.92 (43.98)

Post

**169.12 (26.95)

*176.87 (20.83)

*165.47 (48.02)

Pre

143.27 (31.00)

158.69 (37.18)

143.54 (37.18)

Post

*150.31 (28.13)

**166.57 (17.66)

148.02 (35.87)

Pre

130.06 (10.17)

127.34 (13.90)

130.72 (11.42)

Post

135.75 (12.11)

125.78 (13.06)

132.67 (17.37)

Velocity (cm/s)

Stride Length
(cm)

Cadence (steps
per minute)

Bracketed Numbers represent standard deviations.
* P<.05 with Fisher’s LSD post hoc within groups
**P<.01 with Fisher’s LSD post hoc within groups

Table 7: Measures of balance and postural control
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m-CTSIB
Postural Stability
Test (PST)

Full Sensory
Availability
Pre
Post
Somatosensory
Dominant
Pre
Post
Visual Dominant
Pre
Post
Vestibular Dominant
Pre
Post
Overall
Pre
Post
Anteroposterior
Pre
Post
Mediolateral
Pre
Post

Rate

Magnitude

Control

0.76 (0.22)
0.80 (0.29)

0.78 (0.21)
0.82 (0.29)

0.85 (0.31)
0.76 (0.25)

1.26 (0.46)
1.28 (0.50)

1.34 (0.33)
1.56 (0.63)

1.73 (1.11)
1.62 (0.62)

1.15 (0.30)
1.21 (0.40)

1.42 (0.49)
1.43 (0.63)

1.32 (0.45)
1.24 (0.48)

2.9 (0.77)
2.9 (1.00)

3.3 (1.25)
3.15 (1.11)

3.24 (1.26)
3.43 (1.85)

1.38 (0.29)
1.54 (0.50)

1.68 (0.52)
1.78 (0.61)

1.85 (0.51)
1.71 (0.77)

0.98 (0.37)
0.97 (0.39)

1.25 (0.49)
1.25 (0.56)

1.26 (0.51)
1.15 (0.58)

0.78 (0.24)
0.96 (0.37)

0.88 (0.25)
1.01 (0.32)

1.07 (0.34)
1.03 (0.47)

Full sensory availability=eyes open on firm surface, somatosensory dominant=eyes
closed on firm surface, visual dominant=eyes open on foam surface, vestibular
dominant=eyes closed on foam surface. Values are representative of deviations from
the centre of the platform. Bracketed numbers represent standard deviations. mCTSIB, modified clinical test of sensory integration on balance.
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24
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UPDRS-III

22
21
20
19
18
17

*
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RATE (n=13)
MAGNITUDE (n=13)
CONTROL (n=13)

TIME

Figure 2: UPDRS III change over time. A main effect of time was reported for all
participants. At post hoc, only the RATE group showed significant improvement
*P<.05 Fisher’s LSD Post hoc within groups

DISCUSSION
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The aim of the current study was to evaluate the influence of different types of
afferent feedback elicited from exercise have on the motor symptoms of PD. Results
showed that a high sampling rate of afferent feedback was the most therapeutic, as
only the RATE group which trained at a high cadence significantly improved their
UPDRS-III symptom scores at post. Furthermore, participants in this condition
improved on an upper limb subscore of the UPDRS-III. Since treadmill training
involves little use of the upper limbs, the improvement in upper limb functioning
cannot be explained by practice or motor learning theories, but rather may be
indicative of an improvement in BG functioning. Lastly, considering that intensity,
type, frequency, and duration of training were matched between all training groups,
the type of afferent feedback that exercise generates must be a key consideration for
exercise prescription for those with PD, as this study demonstrated that a high rate of
afferent feedback is most effective in regards to improving the motor symptoms of
PD.
The hypothesis that high rates of afferent somatosensory feedback from
muscle spindles and golgi tendon organs (GTO’s) facilitates the motor symptom
relief seen from exercise was initially proposed by Alberts et al. Their high cadence
protocol showed a 35% improvement in UPDRS-III scores compared to regular
cadence exercise control group. The current study supports the Alberts et al. findings
regarding the therapeutic effect of high cadence exercise, but showed a more modest
20% improvement in UPDRS-III. This is likely because the current study included
participants that were much less severe and were assessed during the “on” state of
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medication, potentially contributing to a ceiling effect. Also, the cadence was slightly
slower in the current study (80.21 rpm in current, compared to 85.8 rpm in Alberts et
al.). This eludes to the possibility that participants may not have trained with a fast
enough cadence to achieve maximal benefits. This was due to the exercise occurring
on a treadmill in the current study, and it being more difficult to maintain a fast
cadence while walking opposed to bicycling.
Unfortunately, the mechanism explaining why a high rate of somatosensory
feedback is therapeutic still remains unknown. However, the high sampling rate of
afferent information from muscle spindles and GTOs, which propagates up the dorsal
column-medial lemniscus pathway into the thalamus may act as a pacemaker and
perturb the abnormal oscillatory rhythms in the beta frequency between the BG and
thalamus that have been reported to occur in PD (Brown et al., 2001; Marsden et al.,
2001). After multiple sessions of high rate exercise, the abnormal spike in beta band
frequencies reported during movement in PD may be attenuated, causing
improvements in motor symptoms.
Alongside of changes in UPDRS-III scores, improvements were reported in
spatiotemporal aspects of gait. Due to the intervention being treadmill based,
improvements in gait were expected across all groups as a result of motor learning.
This is congruent with previously completed treadmill studies that have shown
improvements in gait (Herman et al., 2007; Fisher et al., 2008; Miyai et al., 2000;
Cakit, Saracoglu, Hakan & Erdem, 2007; Pohl, Rockstroh, Ruckriem, Mrass &
Merholz, 2003). However, this study was the first treadmill training paradigm to
compare varying forms of somatosensory feedback and their therapeutic effects on
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gait. During self paced gait, improvements were observed in velocity and stride
length, however, only for the RATE and CONTROL conditions (Table 4). Although
not significant, both stride length and velocity were considerably higher at “pre” for
the MAGNITUDE group possibly explaining why this group did not improve after
the intervention. During fast paced gait, significant improvements in velocity were
observed in all conditions while only the RATE and MAGNITUDE groups increased
their stride length (Table 5). Typical Parkinsonian gait consists of a slow walking
velocity caused by a shorter step length (Morris, Iansek, Matyas & Summers, 1996).
Usually, a higher cadence is employed as a compensatory mechanism for a shorter
stride length (Morris, Iansek Matyas & Summers, 1994). In the current study, changes
in cadence were not significant for self paced or maximal gait speeds in any group,
leading us to conclude that treadmill walking improves gait velocity by improving
step length, which is the root cause of slow walking in PD. Improvements in gait in
the current study are similar to previously completed treadmill programs that are
acute (Pohl, 2003) and long term, ranging from moderate (Miyai, 2000) to intense
(Herman, 2007; Fisher, 2008) aerobic intensity, the use of body weight support
(Miyai, 2000), and speed dependent training (Cakit, 2007). A wide variety of
treadmill programs including the current study have demonstrated that treadmill
training is a safe and effective therapy for improving gait in PD.
The precise mechanism explaining why treadmill training can improve gait is
still unknown. One inherent characteristic of a treadmill is that it moves at a constant
speed, and has been demonstrated to promote more rhythmic and uniform gait
(Frenkel-Toledo, Giladi & Peretz, 2005; Lim, Van Wegen, de Goede et al., 2005).
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Thus, the somatosensory message from receptors in the legs and feet is more
rhythmic and may promote neuroplastic changes in the CNS to areas responsible for
pace and rhythm of gait at either spinal or supraspinal areas. Interestingly, during fast
paced walking, only conditions that received altered somatosensory feedback (RATE,
MAGNITUDE) improved their step length. The effectiveness of altered feedback
during maximal paced walking may be due to the proprioceptive deficits reported in
PD (Rickards & Cody, 1997; Khudados, Cody & O’Boyle, 1999). The altered
somatosensory feedback generated from the ankle weights, or the faster sampling of
somatosensory information from the high cadence RATE group, may improve how
this information is being processed. The improved proprioception may lead to a
greater extensor load response in which the afferent feedback causes an increased
output from the extensors in the lower leg (Dietz & Duysens, 2000). A greater
extensor load response contributes to greater force at toe off, and thus, a greater step
length and velocity (Dietz & Colombo, 1998).
Due to treadmill training being based upon walking, it is difficult to determine
if improvements are from a practice effect, or an improvement in BG functioning. If a
practice effect were to explain the improvements in gait velocity, those in the RATE
group would likely have relied on an increased cadence to improve gait velocity.
However, this was not the case, as only stride length was increased significantly.
Furthermore, since no improvements were detected in any measures of postural
control, improvements in gait cannot be attributed to improvements in balance. Since
all participants were harnessed during treadmill walking, it is likely that balance was
not stressed during the intervention, and thus not improved.
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Aside from manipulations in somatosensory feedback between groups, it is
important to note that the RATE group also differed in the amount of steps they took,
which was a requisite of maintaining a fast cadence and thus a high rate of
somatosensory feedback. High cadence walking should be considered more
volitionally controlled than self-paced walking because the participant must
constantly attend to the maintenance of a fast cadence, which is an unnatural
adaptation. This leads to an alternative explanation for motor symptom improvement
in the RATE group explained by goal directed exercise. In healthy individuals, motor
performance relies on an interaction of volitional and automatic control centers
(Mazzoni & Wexler, 2009). As PD progresses, the loss of dopaminergic projections
to brain centers responsible for the automatic control of movement force PD patients
to rely more heavily on volitional control centers (Redgrave, Rodriguez, Smith et al.,
2010). This reliance on volitional control for movements causes those with PD to
carry larger cognitive loads to ensure successful motor control, which may lead to
difficulties while performing more complex and intricate movements. Therefore,
goal directed exercise, which is the practice of certain activities that lead to improved
performance, may be able to improve the cognitive aspect of motor output by making
actions more learned and automatic (Petzinger, Fisher, McEwen et al., 2013). In the
current study, the RATE group was the most goal directed of the conditions, due to
participants having to maintain a high cadence during walking. High cadence
walking should be considered goal directed exercise because the maintenance of a
high cadence is an unnatural movement, and requires constant volitional control.
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Goal directed movement may lead to neuroplastic changes that revert motor outputs
that were volitional movement back to more natural and automatic.
IMPLICATIONS
The current study provides evidence that high rates of somatosensory
sampling may be a key attribute of exercise in regards to improvements on motor
symptoms of PD. Those prescribing aerobic exercise to PD patients should consider
incorporating exercise that is high rate in nature (fast cadence). Future research
examining the therapeutic contributions of varying forms of somatosensory feedback
should include outcome measures that examine BG functioning directly either by
transcranial magnetic stimulation or positron emission tomography. The use of these
objective measures will provide more in depth evidence of how altered
somatosensory feedback may be improving BG functioning.
LIMITATIONS
Due to the intense nature of the exercise, only those with mild to moderate PD
with minimal gait impairment are able to actually perform the exercise properly. Due
to time and equipment constraints, the sample was limited to 13 in each group. A
potential confounder in the study was that the amount BWS that each participant used
over the course of the exercise sessions was not recorded. With varying amounts of
BWS, more or less load is experienced by the participant during exercise. The
varying amount of load during gait is a concern due to GTO activation (being
sensitive to load) was a main manipulation in the study and is an uncontrolled for
confounder. Additionally, the average heart rate data was generated using a 220-age
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Karvonen formula. An individually generated maximum heart rate for each
participant during pre-testing would have been a more accurate method of
determining average heart rate. Lastly, the use of beta blocking medication that is
common in an older population may have lead to heart rates readings that were not
representative of the intensity of exercise that was being performed. Issues with heart
rate accuracy lead to the possibility that groups did not train at matched aerobic
intensities, introducing a possible confounder explaining differences between groups.
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The purpose of this additional results section is to provide an objective
measure of how upper limb motor performance was affected by the exercise
interventions. Since treadmill exercise can be considered mainly lower limb
dominant, improvements in upper limb tasks unrelated to the intervention may be
representative of overall basal ganglia improvement, as opposed to lower limb
improvements that may be explained by practice or the principle of specificity.
Although the UPDRS-III has a thorough section devoted to the upper limbs, the
subjective nature of the assessment often draws criticism for its lack of sensitivity.
To acknowledge this, two objective measures of upper limb function were tested at
pre and post.
The first objective measure of upper limb function was performance on a
grooved pegboard, which has previously been shown to strongly correlate to overall
UPDRS-III scores (Sage, Bryden, Roy & Almeida, 2012). The other objective
measure was the Kinesia Homeview tablet, which emulates the upper limb tasks of
the UPDRS-III, but generates scores from an accelerometer on the hand that is being
assessed. This device has been previously validated and correlates strongly to clinical
tremor (Giuffrida, Riley, Maddux, and Heldman, 2009), and bradykinesia scores
(Heldman et al., 2011). Additionally, a Pearson’s correlation was used to examine
how closely related the grooved pegboard and Kinesia Homeview scores were to the
current gold standard of motor symptom severity within PD; the UPDRS-III. All
tests were conducted in the week prior to the start of the intervention (Pre), and again
during the week following the cessation of the intervention (Post).
Kinesia Homeview Assessment
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The Kinesia tablet receives data from an accelerometer placed on the pointer
finger of each hand. The accelerometer provides a score from 0-4 on resting tremor,
postural tremor, action tremor, rapid alternating movements, finger taps, and
bradykinesia (hand grasps). For the movement based tasks separate scores for
velocity, rhythm, and amplitude score are provided. All scores were summed for the
respective hand (less affected, more affected). More affected side was determined by
the higher UPDRS-III score for the right or left hand.
Grooved Pegboard
A 25 peg Lafayette Instruments Grooved Pegboard was used. Participants
were timed during both the place and removal phases for each hand for two trials
each. Participants were given a maximum time of 5 minutes. The mean times for the
two trials were averaged, and divided by the amount of successfully placed or
removed pegs to provide a rate (seconds/peg).
Statistical Analysis:
For the Homeview Kinesia and grooved pegboard, a 3X2 repeated measures
ANOVA (groups x time) was used. For the correlation, a Pearson’s correlation was
used. Significance for all tests was set at 0.05.

Results:
Kinesia Homeview Assessment
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1. Affected limb
An interaction between Group and Time (F(2,36)=3.69, p<.05) was found for
Kinesia Homeview symptom score for the more affected limb. Fisher’s LSD post
hoc analysis showed that only the MAGNITUDE group improved significantly
(Table 8).
2. Non-Affected limb
No significant differences were observed in the non-affected limb in the
Kinesia Homeview assessment (Table 8).
Grooved Pegboard
No significant differences were reported in the place or remove phase of the
grooved pegboard task (Table 9).
Correlational Results
Grooved pegboard “place” with more affected limb correlated to UPDRS-III
(r=0.61,p<.05) and UPDRS-III UL (r=0.31, p<.05). Place phase for less affected
limb correlated only to total UPDRS-III score (r=0.50, p<.05) (Table 10).
Kinesia Homeview tablet with the more affected limb correlated strongly to
overall UPDRS-III (r=0.73, p<.05) and UPDRS-III UL (r=0.65, p<.05). Kinesia
Homeview score on the less affected limb also correlated significantly to UPDRS-III
(r=0.55, p<.05) and UPDRS-III UL (r=0.44, p<.05) (Table 10).

Table 8: Kinesia Homeview assessment
Rate

Magnitude

Control

54

More affected limb
Pre

13.60 (4.32)

14.91 (5.58)

15.58 (4.13)

Post

13.99 (5.03

*12.32 (5.62)

14.2 (3.31)

Pre

12.61 (3.90)

11.65 (4.77)

13.17 (3.22)

Post

12.06 (4.15)

11.34 (4.43)

12.07 (2.68)

Less affected limb

*P<.05 Fisher’s LSD post-hoc within groups.

Table 9: Grooved pegboard performance
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Rate

Magnitude

C

Pre

4.4 (1.69)

11.66 (25.54)

8.41

Post

3.97 (1.68)

17.45 (45.50)

5.52

Pre

0.86 (0.17)

0.97 (0.29)

1.13

Post

0.83 (0.19)

0.93 (0.32)

0.92

Pre

5.33 (4.18)

8.87 (9.53)

9.19

Post

4.53 (1.33)

7.87 (9.16)

6.96

Pre

0.88 (0.14)

1.06 (0.26)

1.18

Post

0.86 (0.14)

1.00 (0.30)

1.37

Less Affected "Place"

Less Affected "Remove"

More Affected "Place"

More Affected "Remove"

All values are seconds per peg. Bracketed numbers represent standard deviations.

Table 10: Correlations of upper limb measures to UPDRS-III

56

Grooved Pegboard

Kinesia Tablet

More Affected Place

Less Affected Place

More Affected

Less Affected

UPDRS III PRE

*0.61

*0.5

*0.73

*0.55

UPDRS III UL PRE

*0.36

0.29

*0.65

*0.44

Pearson product-moment correlation coefficients
*p<.05
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Grand Discussion
The primary objective of this randomized, controlled trial was to understand
the therapeutic contributions of somatosensory feedback manipulations during
exercise programs for those with PD. The purpose of examining this was to uncover
potential mechanisms responsible for improvements in cardinal Parkinsonian motor
symptoms from successful exercise interventions. Having a greater understanding of
the mechanism underlying therapeutic responses from exercise in PD is necessary, as
it facilitates the development of more effective exercise prescription, and ideally
establish exercise as a primary adjunct treatment for those with PD.
The greatest challenge with understanding the mechanism(s) responsible for
the therapeutic effects of exercise is that the modalities reported to be successful in
improving the motor symptoms of the disease have been diverse in nature. Thus,
elucidating which components of exercise (type, frequency, duration, intensity) that
possess therapeutic potential is difficult, as they range from aerobic interventions
ranging from moderate (Miyai et al. 2000; Ridgel et al., 2009) to intense (Fisher et
al., 2008; Herman, Giladi, Gruendlinger & Hausdorff, 2007), to strength training
(Corcos et al., 2013), and body awareness based exercises (Li et al., 2012; Sage &
Almeida, 2009; Sage & Almeida 2010). One trait or component of exercise that
appears to be common among all programs is that they are long term studies with
repeated bouts of exercise. Studies that have reported UPDRS-III improvement as a
result of exercise have been longitudinal designs with a minimum duration of 4 weeks
(Miyai, 2000), with most others ranging from 8-12 weeks (Herman, 2007; Sage,
2009; Sage 2010; Ridgel, 2009). In regards to intensity, average heart rate data is not
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provided in most studies, making it difficult to provide a threshold value that is
necessary to maintain in order to obtain therapeutic benefits. This was addressed in
the current study by ensuring all exercise groups trained at a matched age adjusted
heart rate which ranged from 64% to 68% of a Karvonen based AAMHR. A major
finding in the current study was that improvements in UPDRS-III were different
between groups despite all groups exercising at a matched AAMHR. This led us to
conclude that not all aerobic exercise has the same therapeutic potential, and that the
somatosensory feedback generated from exercise is an important trait of exercise to
consider.
Due to the wide array of exercise modalities shown to be successful in
improving the motor symptoms of PD, skeptics would argue that practically any and
all exercise possesses therapeutic possibility for those with PD. To an extent, this
argument is valid. However, recent evidence stemming from more carefully
designed studies employing blinded assessors, randomization, and the inclusion of
suitable control groups have shown that only specific types of exercise have the
ability to improve the motor symptoms of PD. In particular, Ridgel, Vitek & Alberts
(2009) examined two bicycle based aerobic interventions that were matched in
intensity (age adjusted maximum heart rate), duration, and frequency, while
manipulating pedaling cadence between the groups. Despite the aforementioned
exercise traits being similar, only the group which pedaled at a fast cadence reported
improved motor symptoms. This was a critical finding because it was the first study
to demonstrate that not all aerobic exercise possesses the same therapeutic potency.
Although the sample was limited, the drastic improvements reported in the high
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cadence group merited further investigation as to why high cadence exercise was
therapeutic.
In the current study, we attempted to conduct a randomized, controlled trial
including three aerobic treadmill programs that were also comparable in regards to
intensity, duration, and frequency. The main manipulation between groups was the
somatosensory feedback that each of the different treadmill conditions elicited.
Randomization was successful, as groups at pre-test were matched for symptom
severity (UPDRS-III), age, and self-paced walking velocity. Furthermore, intensity of
exercise (age adjusted maximum heart rate) was successfully matched between
treadmill interventions. This was a crucial component of the study to ensure that
differing levels of aerobic intensity during exercise would not be a confounder
between groups. In the current study, the RATE and MAGNITUDE conditions were
considered to be the experimental conditions hypothesized to lead to motor symptom
improvements (UPDRS-III), whereas the CONTROL group was meant to serve as the
active comparator. The inclusion of an active comparator control group was another
key aspect of the study, as a non-exercising control group is often used in PD exercise
based studies. While still better than no control group, a non-exercising control may
not adequately account for potential bias from the placebo of being involved in a
study and receiving care, which can be particularly powerful in a Parkinsonian
population (Lidstone, 2014).
The primary finding was that the RATE condition was the only group to
significantly improve their UPDRS-III scores. Furthermore, when all groups were
collapsed together, UPDRS-III scores improved as a main effect of time. This led to
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the conclusion that although all types of treadmill training in the current study should
be considered successful, high cadence exercise (RATE group) was the most effective
in reducing the motor symptoms of PD. The success of the RATE condition supports
another high cadence exercise program that was successful, albeit on treadmill rather
than bicycle (Ridgel et al., 2009). Ridgel also reported an improvement on an upper
limb task unrelated to the exercise intervention, which was proposed to be an
indicator of overall basal ganglia functioning. Similarly, in the current study, an
upper limb subscore of the UPDRS-III improved in only the RATE group. Since
treadmill walking minimally involves the upper limbs, the transfer of motor symptom
improvement to the upper limbs may be indicative of improvements in basal ganglia
functioning resulting from exercise. It is proposed that the rapid and rhythmic pulses
of somatosensory feedback generated from high cadence exercise may be interacting
with the basal ganglia, and recovering its ability to control motor output.
The exact mechanism explaining how a high rate of somatosensory feedback
improves the motor symptoms of PD remains unclear. However, the high frequency
of rhythmic afferent feedback generated from high cadence exercise may act as a
pacemaker and perturb the abnormal rhythms that have been reported to occur within
the Parkinsonian basal ganglia (Brown et al., 2001; Marsden, Limousin-Dowsey,
Ashby, Pollak & Brown, 2001). These abnormal oscillatory rhythms recorded from
the subthalamic nucleus are prominent in the 20 Hz range, or the “beta band” (Brown,
2001). This spike in beta band frequency is not present in healthy subjects, is
attenuated by dopaminergic medication and deep brain stimulation, and lastly
correlates to bradykinesia and rigidity based motor symptoms (Kuhn et al., 2006;
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Kuhn et al., 2008; Kuhn et al., 2009). This pacemaker effect is plausible because
input from the mechanoreceptors propagates up the medial lemniscus pathway which
interacts with the thalamus; the relay centre for the basal ganglia. After repeated high
cadence exercise sessions, the abnormal spike in beta band frequencies that occur
during movement in PD may be altered by the fast rate of somatosensory feedback
that high cadence exercise generates. Although further research would be needed to
confirm this hypothesis, it is proposed that the somatosensory feedback generated
from high cadence exercise may adjust the abnormal oscillatory rhythms within the
basal ganglia in a manner similar to dopaminergic medication and deep brain
stimulation, provoking long lasting therapeutic effects as a result.
The MAGNITUDE group was included in the study in an effort to examine
the therapeutic effects of another variant of somatosensory feedback during treadmill
walking. However, instead of altering the rate at which the somatosensory feedback
is being generated, the ankle weights were intended to elicit a response greater in
magnitude from tension sensitive golgi tendon organs in the lower limbs of the
participant. The rationale for including this somatosensory feedback manipulation
was to emulate the feedback that exercise interventions such as strength training, Tai
Chi, and PD SAFEx generate. The aforementioned exercises involve aspects of slow,
load bearing movements (a lunge in PD SAFEx or Tai Chi, and resistance training in
general). Although these exercises differ from each other, they all generate a similar
type of somatosensory feedback which is greater in magnitude, particularly from
tension sensitive GTO’s. Although the exact mechanism leading to the therapeutic
benefit of these body awareness exercises is unknown, the feedback from tension
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sensitive GTO’s may aid in the participant’s ability to properly attend to their
movements, as the increased output of afferent signaling may help overcome the
proprioceptive deficits reported in PD (Khudados, Cody & O’Boyle, 2009; Rickards
& Cody, 2007). Thus, the hypothesis was that if a greater afferent signal from
somatosensory receptors into the central nervous system contributes to the therapeutic
effects reported from these types of exercises, then the MAGNITUDE condition
would show improvements in the UPDRS-III in the current study. However, in the
current study UPDRS-III scores for the MAGNITUDE group did not significantly
improve at post-test, implying that a greater magnitude of somatosensory feedback
may not be as therapeutic as a high rate of feedback. Furthermore, the therapeutic
benefits generated from slower, load bearing exercise interventions may not be reliant
on the magnitude of somatosensory feedback they generate, but rather other factors.
For instance, in resistance based exercise, repetitive training sessions have been
reported to increase cortical excitability in healthy controls (Kidgell, Stokes,
Castricum & Pearce, 2010), a measure that has been reported to be worse in a
Parkinsonian population and in part responsible for the pathology of the disease
(Valls-Sole, Pascual-Leone, Brasil-Neto, Cammarota, McShane & Hallett, 1994).
Improvements in postural control and gait from Tai Chi have been attributed to
improvements in muscular strength of the lower limbs, while mechanisms responsible
for upper limb motor symptom relief in these studies still remain unclear (Li et al.,
2012). Further research is needed to understand the mechanism responsible for
improvements in motor symptoms of PD reported in body awareness based exercises.
Body weight support during treadmill training

64

The use of body weight support (BWS) during treadmill originally arose from
gait training studies in stroke populations whose motor impairments were too severe
to walk without the aid of an assistive device. Their application was then adapted for
use in the Parkinsonian population, who similarly may have motor disabilities
preventing them from achieving and maintaining an intensity of exercise necessary
for motor symptom improvement. Miyai et al. (2000) were the first to employ the use
of BWS in a Parkinsonian population. Their 6 week program yielded a significant 3.2
point improvement in UPDRS-III. Their study did not report cadence or average
speed at which the participants trained at, but did mention that the maximum training
speed was 3.0 km/h. The greater 4.5 point improvement in UPDRS-III that the
RATE group reported in the current study reported program was likely due to the
participants walking at a faster velocity (5.63 km/h in the RATE group) and more
importantly, with a more rapid cadence which generates a higher rate of
somatosensory feedback. Interestingly, in the current study, the MAGNITUDE and
CONTROL conditions were fairly similar to the Miyai intervention which reported
significant improvements in UPDRS-III. However, an important difference between
ours and Miyai’s study was that UPDRS-III assessments in the Miyai study were
performed by an assessor who was not blinded to group assignment. Lastly, in the
Miyai study, the standard deviations about the means at pre and post were
considerably smaller than in the current study (1.2 in Miyai compared to 6.93 in
MAGNITUDE and 8.64 in CONTROL). Less interindividual variability may have
facilitated the finding of a statistical difference between pre and post tests.
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The use of BWS in the current study was employed to have the ability to
adapt treadmill exercise to a wider spectrum of locomotor and balance disability. This
was especially important for the high cadence RATE group, as it is difficult to
maintain a high cadence for an extended period of time without the aid of an assistive
device, such as a harness. Although it is beneficial to be able to adapt exercise to a
wide variety of participants, the use of BWS may have been the reason for why there
were no improvements reported in any of the balance measures. It is proposed that
the use of BWS minimizes the dynamic challenges faced by the participant to
maintain balance during gait, explaining why no improvements in balance were
reported. It is proposed that future studies employing treadmill training within PD or
other disabled populations still take advantage of BWS to adapt the exercise to the
ability of the participant. However, the minimum amount of BWS required to achieve
and maintain a proper gait pattern should be used to still allow the balance and
postural control of the participant to be challenged.
Additional Outcome Measures
Additional measures that examined upper limb motor function were included
within the assessment battery in an effort to examine if treadmill exercise, which is
predominantly lower limb based, could lead to upper limb symptom improvement.
Improvement in tasks completely unrelated to the exercise intervention may be
indicative of a change in basal ganglia functioning compared to outcome measures
similar to treadmill walking, such as spatiotemporal aspects of gait. The UPDRS-III
has a thorough upper limb section and is considered the gold standard for assessment
of the motor symptoms of PD. However, due to its subjective nature, has drawn
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criticism for accuracy and validity. Due to this, objective measures to compliment the
UPDRS-III are a valuable addition to the test battery.
The Kinesia Homeview assessment mimics upper limb tasks from the
UPDRS-III, but captures movement data from an accelerometer placed on the index
finger of the participant. The results from the Kinesia Homeview showed a group by
time interaction revealing an upper limb improvement in the MAGNITUDE group for
the participants more affected limb, while RATE and CONTROL groups did not
differ significantly. This finding was surprising as it was in direct opposition to the
results found from the upper limb sub score of the UPDRS-III, which showed
improvement for the RATE group only. This conflicting result may in part be
explained by the MAGNITUDE group having a higher score at pre in the Kinesia
(14.91, compared to 13.6 in the RATE group), while having a more closely matched
UPDRS-UL score. Although the objective nature of the Kinesia is appealing,
research regarding its validity is still limited. Existing research shows that the
Kinesia system can accurately assess tremor (Giuffrida, Riley, Maddux & Heldman,
2009) and bradykinesia (Heldman et al., 2011), however, its ability to emulate the
other upper limb measures on the UPDRS-III is questionable. For this reason, it is
recommended to employ objective upper limb measures alongside of the Homeview
system.
In addition to the Homeview system, a 25 peg Lafayette instruments grooved
pegboard (GP) was used as an additional outcome measure. Previous work has
shown that the “place” phase of the task correlates strongly with overall UPDRS-III
motor scores (Sage, Bryden, Roy & Almeida, 2002). In the current study, no
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differences in any measures of the GP were reported as a result of the exercise
program. This is likely due to the high standard deviations around the mean values
reported in the GP scores. High standard deviations arise from this task because
participants with severe tremor are often severely challenged compared to those who
are akinetic-rigid dominant. Despite converting values to a seconds per peg rate, the
large variance of the data made it very difficult to discover an effect. Although the
test does correlate well to overall UPDRS-III scores, it is likely that it is not sensitive
enough to detect changes in motor symptoms as a result of exercise. Furthermore,
issues with vision as well as arthritis in the hands may skew the results of this
outcome measure, as it is influenced by non Parkinsonian ailments.
Adverse Events
There were no major adverse events as a result of the current exercise
program. Participants were required to return a PARmed-X with a physician’s
approval which had an accurate description of the requirements of the program.
There were 2 minor injuries as a result of the program, both of which occurred in the
MAGNITUDE group. One participant complained of slight hamstring stiffness, and
the other developed minor back pain. Since both incidents occurred in the
MAGNITUDE group, the ankle weights that this group wore may have contributed to
their injuries. No adverse cardiovascular events occurred as a result of the exercise
program, likely due to the stringent exclusion criteria. However, in future studies, it
is recommended that participants perform a stress test in addition to a PARmed-x
form to ensure that they are capable of tolerating aerobic exercise.
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Although not considered to be an adverse event, some participants complained
about chronic fatigue towards the end of the program as a result of exercise. An
inherent difficulty with exercise studies is that participants may feel obliged to
complete the program despite feeling fatigued. In future studies, it is recommended
that the lead researcher include a section in the informed consent emphasizing that
rest days can be taken if needed.
Since no major adverse events occurred as a result of the exercise program,
the improvements in UPDRS-III scores and spatiotemporal aspects of gait were worth
the risk of participating in the study. Of the 48 people that were initially enrolled in
the program, only 2 experienced an adverse outcome.
Limitations
Developing a suitable and effective exercise program for a PD population was
a difficult endeavor to undertake. A main issue that arose during the design of the
study was the requisite to tailor and adapt this program to make it accessible for as
wide of a disease spectrum as possible. Unfortunately, due to the intense nature of
the intervention, stringent exclusion criterion had to be applied to ensure that those in
the program would be capable of performing the exercise properly, and more
importantly, to ensure that no harm would arise from exercising intensely. In general,
the sample in the current study included those with mild to moderate PD with little to
no gait impairments. This greatly limits the Parkinsonian population that was
represented within this sample and suitable for this type of exercise. Although BWS
can be used to some extent to accommodate the program to those who are more
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severe, most participants still found it very difficult to maintain a high cadence during
gait. In future, it is recommended that high cadence exercise (RATE condition) be
performed on a bicycle, as there are currently mechanical devices that aid in the
maintenance of high cadence pedaling, thus making it less effortful to maintain.
Another limitation was that the amount of BWS that each participant received
per session was not recorded. This leads to the possibility that the use of BWS in the
current study was not equal between groups. Although the data is not available, the
RATE group anecdotally used a much greater amount of BWS than the other
conditions in an effort to facilitate the maintenance of high cadence walking for an
extended period of time. However, since aerobic intensity was very closely matched
between groups, it is still likely that groups performed a comparable amount of work.
The main concern regarding a mismatch of BWS between groups has to do with the
amount of load that is experienced during gait. Since the magnitude of tension
sensitive golgi tendon response was a main manipulation of the study, the varying
amount of load that would be experienced is a possible confounder. However,
reporting the amount of BWS is a difficult task, as the amount is constantly changing
due to the slippage of the harnessing system. Constant, systematic adjustments would
be required in order to report it accurately, as there is no recorded mean value
available from the device.
Another possible limitation has to do with the average heart rate data recorded
during the training sessions. Initially, it was proposed that all participants would
wear a Polar heart rate strap for the collection of average heart rate data.
Unfortunately, the harness that all participants wore made it impossible for the strap
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to stay in place comfortably while providing accurate readings. In substitution for the
Polar heart rate straps, the pulse sensitive handles of the treadmill were used.
Unfortunately, there have been no studies published that have examined the accuracy
of the heart rate monitors on the Biodex Gait Trainer treadmill. A separate issue
regarding the average heart rate statistic is the use of beta blocking medication that is
common in this population. The use of this medication stunts the response of heart
rate from exercise, making it challenging to receive accurate heart rate readings.
Furthermore, autonomic system dysfunction particularly in the sympathetic division
is common in PD populations and may contribute to inaccurate heart rate readings
(Micieli, Tosi, Marcheselli & Cavallini, 2003). In future, to ensure that groups are
appropriately matched, it is recommended that a measure of how much work is
performed is recorded alongside of heart rate. Additionally, a measure of perceived
exertion may be another valuable metric, as it can be indicative of heart rate as well
as blood lactate levels. (Borg, Hassmen & Lagerstrom, 1987). Alternatively, the
generation of an individualized maximum heart rate from a maximal exercise test
prior to training would allow for an accurate average heart rate. However, this test
requires an extended bout of maximal exercise which is likely not feasible in this
population. Issues with heart rate accuracy lead to the possibility that groups did not
train at matched aerobic intensities, introducing a possible confounder explaining
differences between groups.
Lastly, it is questionable whether or not the somatosensory feedback
generated in the MAGNITUDE group was truly representative of the feedback that is
generated in the exercise programs that it was meant to emulate. The additional
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muscle tension from the ankle weights would only elicit a greater golgi tendon
response from the extensors at the hip and knee. The limited stretch response may
not have been widespread enough to accurately represent the kind of somatosensory
feedback generated by Tai Chi, PD SAFEx and strength training. These types of
exercises, especially Tai Chi and PD SAFEx, receive increased somatosensory input
from the legs, trunk, and arms. The gap in somatosensory feedback generated in the
MAGNITUDE group compared to that of the exercises it was meant to emulate may
be a reason why the group did not improve UPDRS-III scores significantly. A
possible method to make the somatosensory feedback more widespread would have
been to apply weights to the wrists of the participants in the MAGNITUDE group.

Conclusion
Despite the limitations of the study, valuable findings in regards to
somatosensory feedback and its therapeutic contributions to exercise were
discovered. The high cadence RATE group proved to be the most effective for motor
symptom improvement, leading to the conclusion that exercise that generates a high
rate of somatosensory feedback likely has a greater therapeutic potential. This finding
stresses the importance of considering the somatosensory feedback that exercise
generates when developing exercise programs for those with PD. Specifically, those
incorporating aerobic exercise into their routines should focus on maintaining a high
cadence, whether the exercise is being performed on a bicycle or treadmill. High
cadence exercise can easily be adapted on a bicycle by using a lower gear with

72

minimal resistance, or on treadmill by using BWS. In regards to the actual aerobic
intensity, a Karvonen based MHR (220-age) should be around 60-70%. This is
supported by the current study, as well as the Ridgel et al. forced exercise programs
that this study was inspired by.
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